Bader I Huwaimel

Dr. Bader I Huwaimel

University of Ha'il, Ha'il, Saudi Arabia
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2024 in Fuel
Verified
Journal Article
Closed access
MNMehru Nisa
Mehru Nisa
KYKareem M. Younes
Kareem M. Younes
BHBader I Huwaimel
Bader I Huwaimel
WKWeam M.A. Khojali
Weam M.A. Khojali
WSWafaa Farouk Soliman
Wafaa Farouk Soliman
AHA.M.A. Henaish
A.M.A. Henaish

19 September 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ARAnis Rehman
Anis Rehman
MIMuhammad Iqbal
Muhammad Iqbal
Barkat A KhanBarkat A Khan
Barkat A Khan
WVWolfgang Voelter
Wolfgang Voelter
BHBader I Huwaimel
Bader I Huwaimel
KHKhaled Hosny
Khaled Hosny
Wounds are the most common causes of mortality all over the world. Topical drug delivery systems are more efficient in treating wounds as compared to oral delivery systems because they bypass the disadvantages of the oral route. The aim of the present study was to formulate and evaluate in vitro in vivo nanoemulgels loaded with eucalyptol for wound healing. Nanoemulsions were prepared using the solvent emulsification diffusion method by mixing an aqueous phase and an oil phase, and a nanoemulgel was then fabricated by mixing nanoemulsions with a gelling agent (Carbopol 940) in a 1:1 ratio. The nanoemulgels were evaluated regarding stability, homogeneity, pH, viscosity, Fourier-transform infrared spectroscopy (FTIR), droplet size, zeta potential, polydispersity index (PDI), spreadability, drug content, in vitro drug release, and in vivo study. The optimized formulation, F5, exhibited pH values between 5 and 6, with no significant variations at different temperatures, and acceptable homogeneity and spreadability. F5 had a droplet size of 139 ± 5.8 nm, with a low polydispersity index. FTIR studies showed the compatibility of the drug with the excipients. The drug content of F5 was 94.81%. The percentage of wound contraction of the experimental, standard, and control groups were 100% ± 0.015, 98.170% ± 0.749, and 70.846% ± 0.830, respectively. Statistically, the experimental group showed a significant difference (p < 0.03) from the other two groups. The results suggest that the formulated optimized dosage showed optimum stability, and it can be considered an effective wound healing alternative.

18 May 2017 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
HWHezhen Wang
Hezhen Wang
BHBader I Huwaimel
Bader I Huwaimel
Kshitij VermaKshitij Verma
Kshitij Verma
JMJames Miller
James Miller
TGTodd M. Germain
Todd M. Germain
PTPaul Trippier
Paul Trippier

18 August 2022 in Materials
Verified
Journal Article
Open access
PDF file
ALAmr Abu Lila
Amr Abu Lila
BHBader I Huwaimel
Bader I Huwaimel
AAAhmed Abdulkarim Alobaida
Ahmed Abdulkarim Alobaida
Talib HussainTalib Hussain
Talib Hussain
ZRZeeshan Rafi
Zeeshan Rafi
AAAbobakr Abozeed
Abobakr Abozeed
New antibiotics are seen as ‘drugs of last resort’ against virulent bacteria. However, development of resistance towards new antibiotics with time is a universal fact. Delafloxacin (DFX) is a new fluoroquinolone antibiotic that differs from existing fluoroquinolones by the lack of a protonatable substituent, which gives the molecule a weakly acidic nature, affording it higher antibacterial activity under an acidic environment. Furthermore, antibiotic-functionalized metallic nanoparticles have been recently emerged as a feasible platform for conquering bacterial resistance. In the present study, therefore, we aimed at preparing DFX-gold nano-formulations to increase the antibacterial potential of DFX. To synthesize DFX-capped gold nanoparticles (DFX-AuNPs), DFX was used as a reducing and stabilizing/encapsulating agent. Various analytical techniques such as UV-visible spectroscopy, TEM, DLS, FTIR and zeta potential analysis were applied to determine the properties of the synthesized DFX-AuNPs. The synthesized DFX-AuNPs revealed a distinct surface plasmon resonance (SPR) band at 530 nm and an average size of 16 nm as manifested by TEM analysis. In addition, Zeta potential results (−19 mV) confirmed the stability of the synthesized DFX-AuNPs. Furthermore, FTIR analysis demonstrated that DFX was adsorbed onto the surface of AuNPs via strong interaction between AuNPs and DFX. Most importantly, comparative antibacterial analysis of DFX alone and DFX-AuNPs against Gram-negative (Escherichia coli and Pseudomonas aeruginosa) and Gram-positive (Staphylococcus aureus and Bacillus subtilis) verified the superior antibacterial activity of DFX-AuNPs against the tested microorganisms. To sum up, DFX gold nano-formulations can offer a promising possible solution, even at a lower antibiotic dose, to combat pathogenic bacteria.

20 July 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Sobhi M. GomhaSobhi M. Gomha
Sobhi M. Gomha
SRSayed Riyadh
Sayed Riyadh
BHBader I Huwaimel
Bader I Huwaimel
MZMohie E. M. Zayed
Mohie E. M. Zayed
MAMagda Abdellattif
Magda Abdellattif
Investigating novel compounds that may be useful in designing new, less toxic, selective, and potent breast anticancer agents is still the main challenge for medicinal chemists. Thus, in the present work, acetylthiophene was used as a building block to synthesize a novel series of thiazole-bearing thiophene derivatives. The structures of the synthesized compounds were elucidated based on elemental analysis and spectral measurements. The cytotoxic activities of the synthesized compounds were evaluated against MCF-7 tumor cells and compared to a cisplatin reference drug, and against the LLC-Mk2 normal cell line using the MTT assay, and the results revealed promising activities for compounds 4b and 13a. The active compounds were subjected to molecular modeling using MOE 2019, the pharmacokinetics were studied using SwissADME, and a toxicity radar was obtained from the biological screening data. The results obtained from the computational studies supported the results obtained from the anticancer biological studies.

22 April 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BHBader I Huwaimel
Bader I Huwaimel
SASaad Alqarni
Saad Alqarni
The development of effective drug delivery systems is vital for enhancing the therapeutic efficacy of anticancer agents, particularly paclitaxel (PTX). Despite its potent anticancer properties, PTX faces limitations due to poor solubility and non-specific distribution, leading to significant side effects. To address these challenges, researchers have explored the use of reduced graphene oxide (rGO) as a nanocarrier. Functionalized rGO exhibits unique physicochemical properties, including high surface area and biocompatibility, which enhance drug loading capacity. This study investigates the adsorption mechanisms of PTX on various functionalized rGO surfaces, utilizing computational methods such as Density Functional Theory and Molecular Dynamics simulations. The results demonstrate that functionalization with hydroxyl (-OH), carboxyl (-COOH), and sulfonic (-SO) groups significantly influences the adsorption energy and charge transfer characteristics of PTX on GO. The adsorption energies calculated for PTX@rGO-OH and PTX@rGO-COOH were found to be -0.76 eV and − 0.91 eV, respectively, indicating physisorption predominantly through hydrogen bonding. In contrast, PTX@rGO-SO exhibited a higher adsorption energy of -2.09 eV, suggesting chemisorption facilitated by stronger covalent interactions. The presence of these functional groups also enhanced the binding affinity and stability of the drug-nanocarrier complex. Charge transfer analysis revealed that the rGO-COOH and rGO-SO systems exhibited significant changes in electronic properties, with charge transfers estimated at -0.16e and − 0.08e, respectively. These results indicate enhanced electronic coupling between PTX and the functionalized rGO surfaces, which can improve drug loading efficiency and release kinetics. The study also highlights the importance of optimizing surface chemistry to maximize drug interactions, leading to improved therapeutic outcomes. In conclusion, the investigation underscores the potential of functionalized graphene oxide as a promising platform for drug delivery systems. The findings, including the adsorption energies and charge transfer data, provide valuable insights into the interactions between PTX and functionalized rGO, paving the way for the design of optimized nanocarriers capable of enhancing the efficacy of anticancer therapies. The continued exploration of these systems is essential for advancing the field of nanomedicine and improving treatment strategies for cancer patients.